Mometasone
- Level
- Commodity
- Parent
- 51422100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51422108This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28Cl2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8HR4QJ6DW8, chemically known as pregna-1,4-diene-3,20-dione, 9,21-dichloro-11,17-dihydroxy-16-methyl-, (11beta,16alpha)- but generally known as mometasone, which bears US NIH Compound Identifier 123620. European Medicines Agency schedules Mometasone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09045MIG. World Health Organization schedules mometasone in its Anatomical Therapeutic Chemical (ATC) Classification. MOMETASONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mometasone under HS 29372200 and SITC 54153. As of Q4 2014, MOMETASONE remains the US FDA Preferred Term for this commodity. Mometasone bears US NLM identifiers UMLS ID C0360564 and NCI Concept Code C66181. SMILES: CLC12C(C3C(C(O)(C(C3)C)C(=O)CCL)(CC1O)C)CCC1=CC(=O)C=CC21C.
Same parent
Under 51422100 · 23Activities that produce or sell this
KBLI · 9Inherited from family 51420000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.